Related Experiment Video
Updated: May 23, 2026
Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling
Published on: August 1, 2016
Engineered troponin C constructs correct disease-related cardiac myofilament calcium sensitivity
Bin Liu1, Ryan S Lee, Brandon J Biesiadecki
1Department of Physiology and Cell Biology, The Ohio State University, Columbus, Ohio 43210, USA.
Abstract:
Aberrant myofilament Ca(2+) sensitivity is commonly observed with multiple cardiac diseases, especially familial cardiomyopathies. Although the etiology of the cardiomyopathies remains unclear, improving cardiac muscle Ca(2+) sensitivity through either pharmacological or genetic approaches shows promise of alleviating the disease-related symptoms. Due to its central role as the Ca(2+) sensor for cardiac muscle contraction, troponin C (TnC) stands out as an obvious and versatile target to reset disease-associated myofilament Ca(2+) sensitivity back to normal. To test the hypothesis that aberrant myofilament Ca(2+) sensitivity and its related function can be corrected through rationally engineered TnC constructs, three thin filament protein modifications representing different proteins (troponin I or troponin T), modifications (missense mutation, deletion, or truncation), and disease subtypes (familial or acquired) were studied. A fluorescent TnC was utilized to measure Ca(2+) binding to TnC in the physiologically relevant biochemical model system of reconstituted thin filaments. Consistent with the pathophysiology, the restrictive cardiomyopathy mutation, troponin I R192H, and ischemia-induced truncation of troponin I (residues 1-192) increased the Ca(2+) sensitivity of TnC on the thin filament, whereas the dilated cardiomyopathy mutation, troponin T ΔK210, decreased the Ca(2+) sensitivity of TnC on the thin filament. Rationally engineered TnC constructs corrected the abnormal Ca(2+) sensitivities of the thin filament, reconstituted actomyosin ATPase activity, and force generation in skinned trabeculae. Thus, the present study provides a novel and versatile therapeutic strategy to restore diseased cardiac muscle Ca(2+) sensitivity.
Insights
Aberrant myofilament calcium sensitivity in cardiac disease can be corrected by engineering troponin C (TnC). Rationally designed TnC constructs restored normal Ca(2+) sensitivity and muscle function, offering a therapeutic strategy for cardiomyopathies.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Biochemistry
Background:
- Aberrant myofilament calcium (Ca2+) sensitivity is a hallmark of cardiac diseases, particularly familial cardiomyopathies.
- Troponin C (TnC) is the primary Ca2+ sensor for cardiac muscle contraction and a key target for therapeutic intervention.
- Correcting altered Ca2+ sensitivity holds promise for alleviating disease symptoms.
Purpose of the Study:
- To test if rationally engineered TnC constructs can correct aberrant myofilament Ca2+ sensitivity and related functions in cardiac disease models.
- To investigate the impact of specific troponin I and troponin T mutations on TnC Ca2+ sensitivity.
- To evaluate the therapeutic potential of modified TnC in restoring cardiac muscle function.
Main Methods:
- Utilized a fluorescent troponin C (TnC) to measure Ca2+ binding in reconstituted thin filament systems.
- Studied three thin filament protein modifications (troponin I/T, missense mutation/deletion/truncation) representing familial and acquired cardiomyopathies.
- Assessed corrected Ca2+ sensitivities, actomyosin ATPase activity, and force generation in skinned trabeculae.
Main Results:
- Restrictive cardiomyopathy mutation (troponin I R192H) and ischemia-induced truncation (troponin I 1-192) increased TnC Ca2+ sensitivity.
- Dilated cardiomyopathy mutation (troponin T ΔK210) decreased TnC Ca2+ sensitivity.
- Engineered TnC constructs successfully normalized Ca2+ sensitivities and restored actomyosin ATPase activity and force generation.
Conclusions:
- Rationally engineered troponin C constructs can effectively correct abnormal cardiac myofilament Ca2+ sensitivity.
- This approach offers a versatile therapeutic strategy for restoring cardiac muscle function in various cardiomyopathies.
- Targeting TnC represents a promising avenue for treating heart muscle diseases associated with altered Ca2+ handling.
Related Concept Videos
01:26Cross-bridge Cycle
01:25Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...